Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace

Sponsor
Mayo Clinic (Other)
Overall Status
Terminated
CT.gov ID
NCT00587795
Collaborator
AirCast LLC (Industry)
1
1
2
31
0

Study Details

Study Description

Brief Summary

Objectives:
  • To obtain clinical evidence for the safety and efficacy in using the StabilAir Wrist
Fracture Brace for the following cases:
  1. Acute (emergency department) treatment of non-displaced, stable extra- articular distal radius fractures;

  2. To obtain comparative data between traditional therapies (sugar tong, plaster backslab, long arm or short arm cast) and the use of the StabilAir brace for each patient qualified by specific criteria.

Hypothesis:
  1. For stable, non-displaced fractures, the StabilAir Brace is as effective as a sugar tong splint in the acute setting. 2) In cases where full forearm immobilization is initially preferred, the StabilAir is effective as a follow-up to sugar tong splitting once the need for full immobilization has passed.
Condition or Disease Intervention/Treatment Phase
  • Device: StabilAir Wrist Brace
  • Other: Placement of sugar tong splint or plaster cast
N/A

Detailed Description

Data Collection and Study Design:

This will be a single center, prospective, randomized controlled trial. The investigators planned to collect data from 80 patients with undisplaced distal radius fractures. Half were to be treated with the plastic back slab or sugar tong splint (if there were an ulnar styloid fracture) and half were to be treated with the StabilAir splint. The initial treatment, which was to occur upon the patient's arrival at the emergency room and prior to study randomization, required full forearm and wrist immobilization in the acute phase treated with sugar tong splinting. At the patient's follow-up visit, which was to happen ≤10 days post injury and initial evaluation, when it was determined that full forearm immobilization was no longer necessary, patients were informed of the study, consented, and randomized (as in the flip of a coin) to one of the two study groups using a computerized randomization process that was controlled by the study coordinator. One study group was to consist of patients treated with either sugar tong splint or plaster casting and the other study group was to consist of patients treated with the StabilAir brace. Throughout entire study, the sugar tong splint/casting patients was to be the control group.

Patients were to be asked to return for the following visits after they were randomized:
  • 10-14 days post randomization

  • 35 to 42 days (5 to 6 weeks) post randomization

  • 77 to 84 days (11 to 12 weeks) post randomization;

  • And at 12 and 24 months.

At each visit they were to have x-rays of their wrist and an exam with the physician. In addition, they were to be asked to complete questionnaires regarding their general health, daily activities and pain.

Study Design

Study Type:
Interventional
Actual Enrollment :
1 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace
Study Start Date :
Apr 1, 2006
Actual Primary Completion Date :
Aug 1, 2008
Actual Study Completion Date :
Nov 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: StabilAir Wrist Brace

One study group will consist of patients treated with the StabilAir Wrist Brace.

Device: StabilAir Wrist Brace
Patient will be placed in a StabilAir Wrist Brace 10-14 days after initial injury and return for follow up visits at 6 weeks; 3, 6, 12 and 24 months.

Placebo Comparator: Control

Study arm will consist of patients that are treated with placement of sugar tong splint or plaster cast.

Other: Placement of sugar tong splint or plaster cast
Patients will receive a sugar tong splint or plaster cast for their wrist fracture. They will return for x-rays and an exam at 6 weeks; 3, 6, 12 and 24 months.
Other Names:
  • Sugar tong splint or plaster cast
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Distal Radius Fracture at 8 Weeks [baseline, 8 weeks]

      The investigators planned to make radiographic assessments using the Stewart Score. The Stewart Score can range from 1 to 12, with a higher score indicating poor function: excellent (0), good (1-3), fair (4-6) and poor (7-12).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Males and Females Age ≥ 18 yrs

    • Undisplaced distal radial fractures (with/without ulnar styloid fractures)

    Exclusion Criteria:
    • Age < 18 yrs

    • Intra-articular fracture - displaced

    • Loss of reduction after cast or brace treatment

    • Excessive comminution (> 50% metophysis)

    • Failed closed reduction (CR) (Unacceptable alignment status post CR: Short >2mm; Dorsal angulation >0° (neutral), Radial inclination < 15°)

    • Ipsilateral ulna fractures (not styloid)

    • Open fracture

    • Senile or dementia or lack of understanding of treatment

    • Previous fracture distal radius

    • Patients with displaced fractures that require pin fixation, external fixation, plate fixation or who qualify for "crystalline injection fracture healing protocol" are excluded from the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic
    • AirCast LLC

    Investigators

    • Principal Investigator: David G Dennison, MD, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    David Dennison, PI, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT00587795
    Other Study ID Numbers:
    • 228-06
    First Posted:
    Jan 7, 2008
    Last Update Posted:
    Aug 2, 2017
    Last Verified:
    Apr 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details One subject was recruited from the Mayo Clinic in Rochester, Minnesota in 2007.
    Pre-assignment Detail
    Arm/Group Title StabilAir Wrist Brace Control
    Arm/Group Description One study group will consist of patients treated with the StabilAir Wrist Brace. StabilAir Wrist Brace: Patient will be placed in a StabilAir Wrist Brace 10-14 days after initial injury and return for follow up visits at 6 weeks; 3, 6, 12 and 24 months. Study arm will consist of patients that are treated with placement of sugar tong splint or plaster cast. Placement of sugar tong splint or plaster cast: Patients will receive a sugar tong splint or plaster cast for their wrist fracture. They will return for x-rays and an exam at 6 weeks; 3, 6, 12 and 24 months.
    Period Title: Overall Study
    STARTED 1 0
    COMPLETED 0 0
    NOT COMPLETED 1 0

    Baseline Characteristics

    Arm/Group Title StabilAir Wrist Brace Control Total
    Arm/Group Description One study group will consist of patients treated with the StabilAir Wrist Brace. StabilAir Wrist Brace: Patient will be placed in a StabilAir Wrist Brace 10-14 days after initial injury and return for follow up visits at 6 weeks; 3, 6, 12 and 24 months. Study arm will consist of patients that are treated with placement of sugar tong splint or plaster cast. Placement of sugar tong splint or plaster cast: Patients will receive a sugar tong splint or plaster cast for their wrist fracture. They will return for x-rays and an exam at 6 weeks; 3, 6, 12 and 24 months. Total of all reporting groups
    Overall Participants 1 0 1
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    NaN
    0
    0%
    Between 18 and 65 years
    0
    0%
    0
    NaN
    0
    0%
    >=65 years
    1
    100%
    0
    NaN
    1
    100%
    Sex: Female, Male (Count of Participants)
    Female
    0
    0%
    0
    NaN
    Male
    1
    100%
    1
    Infinity
    Region of Enrollment (participants) [Number]
    United States
    1
    100%
    1
    Infinity

    Outcome Measures

    1. Primary Outcome
    Title Change in Distal Radius Fracture at 8 Weeks
    Description The investigators planned to make radiographic assessments using the Stewart Score. The Stewart Score can range from 1 to 12, with a higher score indicating poor function: excellent (0), good (1-3), fair (4-6) and poor (7-12).
    Time Frame baseline, 8 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title StabilAir Wrist Brace Control
    Arm/Group Description One study group will consist of patients treated with the StabilAir Wrist Brace. StabilAir Wrist Brace: Patient will be placed in a StabilAir Wrist Brace 10-14 days after initial injury and return for follow up visits at 6 weeks; 3, 6, 12 and 24 months. Study arm will consist of patients that are treated with placement of sugar tong splint or plaster cast. Placement of sugar tong splint or plaster cast: Patients will receive a sugar tong splint or plaster cast for their wrist fracture. They will return for x-rays and an exam at 6 weeks; 3, 6, 12 and 24 months.
    Measure Participants 0 0

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title StabilAir Wrist Brace Control
    Arm/Group Description One study group will consist of patients treated with the StabilAir Wrist Brace. StabilAir Wrist Brace: Patient will be placed in a StabilAir Wrist Brace 10-14 days after initial injury and return for follow up visits at 6 weeks; 3, 6, 12 and 24 months. Study arm will consist of patients that are treated with placement of sugar tong splint or plaster cast. Placement of sugar tong splint or plaster cast: Patients will receive a sugar tong splint or plaster cast for their wrist fracture. They will return for x-rays and an exam at 6 weeks; 3, 6, 12 and 24 months.
    All Cause Mortality
    StabilAir Wrist Brace Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/1 (0%) 0/0 (NaN)
    Serious Adverse Events
    StabilAir Wrist Brace Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/1 (0%) 0/0 (NaN)
    Other (Not Including Serious) Adverse Events
    StabilAir Wrist Brace Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/1 (0%) 0/0 (NaN)

    Limitations/Caveats

    Early termination due to inability to enroll subjects, and concern about subject compliance in the use of the Stabilair wrist brace. The one subject enrolled disliked the brace and quickly withdrew from the study.

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. David Dennison
    Organization Mayo Clinic
    Phone 507-284-7405
    Email Dennison.David@mayo.edu
    Responsible Party:
    David Dennison, PI, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT00587795
    Other Study ID Numbers:
    • 228-06
    First Posted:
    Jan 7, 2008
    Last Update Posted:
    Aug 2, 2017
    Last Verified:
    Apr 1, 2017